Skip to content

About Leuko

A focused team taking on a major medical need.

Improving quality of life and outcomes for cancer patients and others at risk of severe neutropenia, through the first noninvasive white blood cell monitor.

Executive Team

Product Development

Board of Directors

Board of Advisors

Awards

  • MIT delta v

    MIT delta v Accelerator

  • Ashoka

    "Impacto Salud" Award, Ashoka

  • UPM

    "Innovatech" Award, UPM

  • M2D2

    1st Place Winner $200K Competition, M2D2 · 2018

  • MassConnect

    MassConnect

  • MIT $100K

    MIT $100K Entrepreneurship Competition

  • Philips

    Philips Innovation Award

  • Pulse@MassChallenge HealthTech

    1st Place Diamond Prize Winner, Pulse@MassChallenge HealthTech · 2018

  • Rice / Brown School of Engineering

    Rice Brown School of Engineering Tech Innovation Prize

  • Sanitas

    "Patient–Physician Relations" Winner, Sanitas

Our Origin Story

Leuko spun out from the Massachusetts Institute of Technology and the Madrid–MIT M+Visión Consortium. The founders were research fellows in a biomedical technology innovation initiative who felt compelled to solve a big unmet medical need for cancer patients undergoing treatment.

Read more at the MIT Innovation Initiative →

With the support of